A Massachusetts federal judge has agreed to dismiss Pfizer and the plaintiff’s former attorneys in the matter of a former Wyeth Pharmaceuticals employee who alleged his legal team committed fraud during the course of representing him in a wage-and-hour suit against his employer.

The plaintiff, Brett Arbogast, began working for Wyeth in March 2004. During that time, Arbogast complained that his position was misclassified as exempt under the Fair Labor Standards Act. By June of 2004, Wyeth terminated Arbogast. Since that time, Pfizer has become the successor company to Wyeth, according to the Feb. 9 opinion by U.S. District Judge Denise J. Casper of the District of Massachusetts.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]